Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,838Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Nilotinib

Brand Name : TASIGNA

Patent Number : 2491632

Filing Date : 2003-07-04

Strength per Unit : 200 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-07-04

Date Granted : 2009-11-10

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Nilotinib

Brand Name : TASIGNA

Patent Number : 2491632

Filing Date : 2003-07-04

Strength per Unit : 150 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-07-04

Date Granted : 2009-11-10

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Nilotinib

Brand Name : TASIGNA

Patent Number : 2615669

Filing Date : 2006-07-18

Strength per Unit : 200 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-07-18

Date Granted : 2013-11-12

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Nilotinib

Brand Name : TASIGNA

Patent Number : 2614334

Filing Date : 2006-07-18

Strength per Unit : 200 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-07-18

Date Granted : 2015-04-21

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Nilotinib

Brand Name : TASIGNA

Patent Number : 2615669

Filing Date : 2006-07-18

Strength per Unit : 150 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-07-18

Date Granted : 2013-11-12

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Nilotinib

Brand Name : TASIGNA

Patent Number : 2614334

Filing Date : 2006-07-18

Strength per Unit : 150 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-07-18

Date Granted : 2015-04-21

blank